Improved Laboratory Confirmation of Heparin-Induced Thrombocytopenia Type II: Time Course of Antibodies and Combination of Antigen and Biologic Assays

American Journal of Clinical Pathology

Volumn 115, Issue 3, 2001, Pages 432-438

  Harenberg, Job ^a   Wang, Lianchun ^a   Hoffmann, Ursula ^a   Huhle, Günter ^a   Feuring, Martin ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Carbon 14 serotonin release assay; Fluorescence linked immunofiltration assay; Heparin; Heparin induced thrombocytopenia; Thrombosis

Indexed keywords

ANTIGEN; AUTOANTIBODY; CARBON; FLUORESCENT DYE; HEPARIN; SEROTONIN; THROMBOCYTE FACTOR 4;

AGED; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNOASSAY; IMMUNOLOGY; KINETICS; MALE; METABOLISM; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

AGED; ANTIGENS; AUTOANTIBODIES; CARBON RADIOISOTOPES; FEMALE; FLUORESCENT DYES; HEPARIN; HUMANS; IMMUNE COMPLEX DISEASES; IMMUNOASSAY; KINETICS; MALE; MIDDLE AGED; PLATELET COUNT; PLATELET FACTOR 4; SENSITIVITY AND SPECIFICITY; SEROTONIN; THROMBOCYTOPENIA;

EID: 0035289558     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/et2w-5j8e-mfvu-qyah     Document Type: Article

References (22)

1. Kelton JG, Levine MN. Heparin-induced thrombocytopenia. Semin Thromb Hemost. 1986;12:59-62.
2. Chong BH. Heparin-induced thrombocytopenia. Blood Rev. 1988;2:108-114.
3. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood. 1986;67:27-30.
4. Greinacher A, Michels I, Kiefel V, et al. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost. 1991;66:734-736.
5. Tomer A. A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia. Br J Haematol. 1997;98:648-666.
6. Amiral J, Bridley F, Dreyfus M. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost. 1992;68:95-96.
7. Newman PM, Swanson RL, Chong BH. Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low-molecular-weight heparin and heparinoid. Thromb Haemost. 1998;80:292-297.
8. Wang LC, Huhle G, Malsch R, et al. Determination of heparin-induced IgG antibody by fluorescence-linked immunofiltration assay (FLIFA). J Immunol Methods. 1999;222:93-99.
9. Wang LC, Huhle G, Malsch R, et al. Determination of heparin-induced IgG antibody in heparin-induced thrombocytopenia type II. Eur Clin Invest. 1999;29:232-237.
10. Eichler P, Budde U, Haas S, et al. First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heParin ELISA. Thromb Haemost. 1999;81:625-629.
11. Pouplard C, Amiral J, Borg JY, et al. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol. 1999;111:700-706.
12. Look KA, Sahud M, Flaherty S, et al. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis. Am J Clin Pathol. 1997;108:78-82.
13. Greinacher A, Amiral J, Dummel V, et al. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion, 1994;34:381-385.
14. 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol. 1995;104:648-654.
15. Kelton JG, Sheridan D, Brain H, et al. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med. 1984:103:606-612.
16. Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost. 1993;69:344-350.
17. Walenga JM, Jeske WP, Wood JJ, et al. Laboratory tests for heparin-induced thrombocytopenia: a multicenter study. Semin Hematol. 1999;36(1 suppl 1):22-28.
18. Frank MM, Lawley TJ, Hamburger MI, et al. Immunoglobulin G-Fc receptor mediated clearance in autoimmune disease. Ann Intern Med. 1983;98:206-218.
19. Cadroy Y, Amiral J, Raynaud H, et al. Evolution of antibodies anti-PF4/heparin in a patient with a history of heparin-induced thrombocytopenia reexposed to heparin [letter]. Thromb Haemost. 1994;72:783-784.
20. Amiral J, Bridey F, Wolf M, et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost. 1995;73:21-28.
21. Mannik M, Arend WP. Fate of preformed immune complexes in rabbits and rhesus monkeys, J Exp Med. 1971;134:19-28.
22. Amiral J, Marfaing-Koka A, Wolf M, et al. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood. 1996;88:410-416.